Posted Jan. 4, 2013 at 6:55 a.m.

Premium Lock Tranzyme could be in for big paydays from drug giant Bristol-Myers

Published: 2013-01-04 06:55:00
Updated: 2013-01-04 06:55:00

Print this blog post
Transzyme

Tranzyme Pharma, its stock driven under $1 a share in value by recent drug setbacks, reported some good news early Friday - the transfer of several compounds to Bristol-Myers Squibb that could lead to big paydays....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll